Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US15441142Application Date: 2017-02-23
-
Publication No.: US09725441B2Publication Date: 2017-08-08
- Inventor: Young K. Chen , Toufike Kanouni , Zhe Nie , Jeffrey Alan Stafford , James Marvin Veal , Michael Brennan Wallace
- Applicant: CELGENE QUANTICEL RESEARCH, INC.
- Applicant Address: US CA San Diego
- Assignee: Celgene Quanticel Research, Inc.
- Current Assignee: Celgene Quanticel Research, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein LLP
- Main IPC: C07D409/12
- IPC: C07D409/12 ; C07D213/79 ; C07D401/12 ; C07D405/12

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Public/Granted literature
- US20170158681A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2017-06-08
Information query